Cargando…
L-type Amino Acid Transporter 1 Utilizing Ferulic Acid Derivatives Show Increased Drug Delivery in the Mouse Pancreas Along with Decreased Lipid Peroxidation and Prostaglandin Production
[Image: see text] Oxidative stress and pathological changes of Alzheimer’s disease (AD) overlap with metabolic diseases, such as diabetes mellitus (DM). Therefore, tackling oxidative stress with antioxidants is a compelling drug target against multiple chronic diseases simultaneously. Ferulic acid (...
Autores principales: | Tampio, Janne, Markowicz-Piasecka, Magdalena, Montaser, Ahmed, Rysä, Jaana, Kauppinen, Anu, Huttunen, Kristiina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644403/ https://www.ncbi.nlm.nih.gov/pubmed/36027044 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00328 |
Ejemplares similares
-
Hemocompatible LAT1-inhibitor can induce apoptosis in cancer cells without affecting brain amino acid homeostasis
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2020) -
Comparison of Experimental Strategies to Study l-Type Amino Acid Transporter 1 (LAT1) Utilization by Ligands
por: Huttunen, Johanna, et al.
Publicado: (2021) -
Targeting of Perforin Inhibitor into the Brain Parenchyma Via a Prodrug Approach Can Decrease Oxidative Stress and Neuroinflammation and Improve Cell Survival
por: Tampio, Janne, et al.
Publicado: (2020) -
Astrocyte-Targeted Transporter-Utilizing Derivatives of Ferulic Acid Can Have Multifunctional Effects Ameliorating Inflammation and Oxidative Stress in the Brain
por: Montaser, Ahmed, et al.
Publicado: (2019) -
L-Type Amino Acid Transporter 1-Utilizing Prodrugs of Ketoprofen Can Efficiently Reduce Brain Prostaglandin Levels
por: Montaser, Ahmed, et al.
Publicado: (2020)